Mood and anxiety disorders in breast cancer: An update

Current Psychiatry Reviews

Volumn 6, Issue 1, 2010, Pages 56-63

  Montel, Sébastien ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Anxiety disorders; Breast cancer; Mood disorders

Indexed keywords

ANTIDEPRESSANT AGENT; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; FLUOXETINE;

ANXIETY DISORDER; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL ASSESSMENT; DEPRESSION; DISEASE ASSOCIATION; FATIGUE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HORMONAL THERAPY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MANIA; MASTECTOMY; MENTAL HEALTH CARE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD CHANGE; MOOD DISORDER; PATIENT SATISFACTION; PHYSICAL ACTIVITY, CAPACITY AND PERFORMANCE; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; SCREENING; SYMPTOMATOLOGY; THERAPY EFFECT; TREATMENT OUTCOME;

EID: 77950279566     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340010790596535     Document Type: Review

References (89)

1. Fann JR, Thomas-Rich AM, Katon WJ, et al. Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry 2008; 30: 112-126
2. Gandubert C, Carrière I, Escot C, et al. Onset and relapse of psychiatric disorders following early breast cancer: a case-control study. Psychooncology 2009;18:1029-1037
3. Christensen S, Zachariae R, Jensen AB, et al. Prevalence and risk of depressive symptoms 3-4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat 2009; 113: 339-355
4. Mehnert A, Koch U. Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors. J Psychosom Res 2008; 64: 383-391
5. Kim SH, Son BH, Hwang SY, et al. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manage 2008 ; 3: 644-655
6. Lueboonthavatchai P. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J Med Assoc Thai 2007; 90: 2164-2174
7. Shelby RA, Golden-Kreutz DM, Andersen BL. PTSD diagnoses, subsyndromal symptoms, and comorbidities contribute to impairments for breast cancer survivors. J Trauma Stress 2008; 21: 65-72.
8. Mehnert A, Koch U. Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: a prospective study. Psychooncology 2007; 16: 181-188
9. Okamura M, Yamawaki S, Akechi T. Psychiatric disorders following first breast cancer recurrence: prevalence, associated factors and relationship to quality of life. Jpn J Clin Oncol 2005; 35:302-309
10. Chow E, Fan G, Hadi S, Wong J Symptom clusters in cancer patients with brain metastases. Clin Oncol 2008; 20: 76-82.
11. Kissane DW, Grabsch B, Love A, Clarke DM Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiatry 2004; 38: 320-326
12. Partridge A, Adloff K, Blood E, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst 2008; 100: 243-251
13. Salkovskis PM. Somatic problems. In Hawton K, Salkovskis PM, Kirk J, Clark DM, Eds. Cognitive Behaviour for Psychiatric Problems - A practical Guide Oxford. Oxford Medical Publications 1989; pp. 235-276
14. Schairer C, Brown LM, Chen BE, et al. Suicide after breast cancer: an international population-based study of 723,810 women. J Natl Cancer Inst 2006; 98: 1416-1419
15. Costanzo ES, Lutgendorf SK, Mattes ML, et al. Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. Br J Cancer 2007; 97: 1625-1631
16. Krüger A, Leibbrand B, Barth J. Course of psychosocial distress and health-related quality of life in patients at different age groups during cancer rehabilitation. Z Psychosom Med Psychother 2009; 55(2): 141-161
17. Bardwell WA, Natarajan L, Dimsdale JE, et al. Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol 2006; 24: 2420-2427
18. Humpel N, Iverson DC. Depression and quality of life in cancer survivors: is there a relationship with physical activity? Int J Behav Nutr Phys Act 2007; 4: 65.
19. Von Ah D, Kang DH. Correlates of mood disturbance in women with breast cancer: patterns over time. J Adv Nurs 2008; 61: 676-689
20. Palesh OG, Shaffer T, Larson J, et al. Emotional self-efficacy, stressful life events, and satisfaction with social support in relation to mood disturbance among women living with breast cancer in rural communities. Breast J 2006; 12:123-129
21. Banou E, Hobfoll SE, Trochelman RD. Loss of resources as mediators between interpersonal trauma and traumatic and depressive symptoms among women with cancer. J Health Psychol 2009; 14: 200-214
22. Grigoriadis S, Robinson GE. Gender issues in depression. Ann Clin Psychiatry 2007; 19: 247-255
23. Golstein D, Bennett B, Friedlander M, et al. Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer 2006; 6: 240.
24. Jenkins V, Shilling V, Deutsch G, et al. A 3 year prospective study of the effects of ajuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 2006; 94: 828-834
25. Donovan KA, Small BJ, Andrykowski MA, et al. Cognitive functionning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 2005; 104: 2499-2507
26. Pacchiarotti I, Mazzarini L, Pellegrini P, et al. A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer. Gen Hosp Psychiatry 2007; 29: 461-463
27. Lee KC, Ray GT, Hunkeler EM, et al. Tamoxifen treatment and new-onset depression in breast cancer patients. Psychosomatics 2007; 48: 205-210
28. Liebens E, Carly B, Pastijn A, et al. Desire for a child and breast cancer. Acta Chir Belg 2008; 108: 83-87
29. Goodwin G.M. Aromatase inhibitors and bipolar mood disorder: a case report. Bipolar Disord 2006; 8: 516-518
30. Barron TI, Connolly R, Bennett K, et al. Early discontinuation of tamoxifen: a lesson for oncologists. Cancer 2007; 110: 2594.
31. Nausheen B, Kamal A. Familial social support and depression in breast cancer: an exploratory study on a Pakistani sample. Psychooncolology 2007; 16: 859-862
32. Meyer L, Aspegren K. Long term psychological sequelae of mastectomy and breast conserving treatment for breast cancer. Acta Oncol 1989; 28: 13-18.
33. Rubino C, Figus A, Lorettu L, et al. Post-mastectomy reconstruction: a comparative analysis on psychosocial and psychopathological outcomes. J Plast Reconstr Aesthet Surg 2007; 60: 509-518
34. Roth RS, Lowery JC, Davis J, et al. Psychological factors predict patient satisfaction with postmastectomy breast reconstruction. Plast Reconstr Surg 2007; 119: 2008-2015
35. Sheehan J, Sherman KA, Lam T, et al. Association of information satisfaction, psychological distress and monitoring coping style with post-decision regret following breast reconstruction. Psychooncology 2007; 16: 342-351
36. Roth RS, Lowery JC, Davis J, et al. Quality of life and affective distress in women seeking immediate versus delayed breast reconstruction after mastectomy for breast cancer. Plast Reconstr Surg 2005; 116: 993-1002.
37. Knobf T, Sun Y. A longitudinal study of symptoms and self-care activities in women treated with primary radiotherapy for bresat cancer. Cancer Nurs 2005; 28(3): 210-218
38. Lee TS, Kilbreath SL, Refshauge KM, et al. Quality of life of women treated with radiotherapy for breast cancer. Support Care Cancer 2008; 16: 399-405.
39. Zigmond AS, Snaith PR. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-370.
40. Ozalp E, Soygür H, Cankurtaran E, et al. Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests. Psychooncology 2008; 17: 668-675
41. Walker J, Postma K, McHugh GS, et al. Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. J Psychosom Res 2007; 63:83-91.
42. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 34: 382-389
43. Montel S, Bungener C. The coping and quality of life in 135 subjects with Multiple Sclerosis. Mult Scler 2007; 13: 393-401.
44. Montel S. & Bungener C. The effects of deep brain stimulation on coping strategies in Parkinson's Disease: A five-year cross-sectional study. Mov Disord 2008; 23:1780-1784
45. Montel S, Bonnet AM, Bungener C. Quality of life in relation to mood, coping strategies and dyskinesia in Parkinson's Disease. J Geriatr Psychiatry Neurol 2009; 22 : 95-102.
46. Zimmerman M, Chelminski I, Posternak M. A review of studies of the Montgomery-Asberg Depression Rating Scale in controls: implications for the definition of remission in treatment studies of depression. Int Clin Psychopharmacol 2004; 19:1-7.
47. Radloff LS. The CES-D scale: A self report depression scale for research in the general population Appl Psychol Meas 1977; 1: 385-401.
48. Hamilton MA rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
49. Beck A.T, Ward CH, Mendelson M, et al. An Inventory for Measuring Depression. Arch Gen Psychiatr 1961; 4: 53-63.
50. Beck AT, Rial WY, Rickets K. Short form of depression inventory: cross-validation. Psychol Rep 1974; 34:1184-1186
51. Love AW, Grabsch B, Clarke DM, et al. Screening for depression in women with metastatic breast cancer: a comparison of the beck depression inventory short form and the hospital anxiety and depression scale. Aust N Z J Psychiatry 2004; 38: 526-531
52. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-55.
53. Hamilton M. Diagnosis and rating of anxiety. Br J Psychiatry 1969; 3: 76-79
54. Fu CW, Tan AW, Sheng F, et al. The prevalence of anxiety symptoms and depressive symptoms in patients with somatic disorders in urban China: a multi-center cross-sectional study. Int J Psychiatr Med 2007; 37(2):185-199
55. Beck AT, Steer RA. Beck Anxiety Inventory Manual. San Antonio, TX: Psychological Corporation 1993.
56. Hopko DR, Bell JL, Armento ME, et al. The phenomenology and screening of clinical depression in cancer patients. J Psychosoc Oncol 2008; 26: 31-51.
57. Jefford M, Mileshkin L, Richards K, et al. Rapid screening for depression-validation of the Brief Case-Find for Depression (BCD) in medical oncology and palliative care patients. Br J Cancer 2004; 91: 900-906
58. Lloyd-Williams M, Shiels C, Dowrick C. The development of the Brief Edinburgh Depression Scale (BEDS) to screen for depression in patients with advanced cancer. J Affect Disord 2007; 99: 259-264
59. Hirai K, Shiozaki M, Motooka H, et al. Discrimination between worry and anxiety among cancer patients: development of a brief cancer-related worry inventory. Psychooncology 2008;17: 1172-1179
60. Navari RM, Brenner MC, Wilson MN. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy. Breast Cancer Res Treat 2008;112:197-201.
61. Chubak J, Buist DS, Boudreau DM.Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat 2008; 112: 123-132
62. González-Pérez A, García Rodríguez LA. Breast cancer risk among users of antidepressant medications. Epidemiology 2005; 16:101-105
63. Coogan PF. Review of the epidemiological literature on antidepressant use and breast cancer risk. Expert Rev Neurother 2006; 6:1363-1374
64. Chien C, Li CI, Heckbert SR, et al. Antidepressant use and breast cancer risk. Breast Cancer Res Treat 2006; 95:131-140
65. Fulton-Kehoe D, Rossing MA, Rutter C, et al. Use of antidepressant medications in relation to the incidence of breast cancer. Br J Cancer 2006 10; 94:1071-1078
66. Schou I, Ekeberg O, Karesen RE. Psychosocial intervention as a component of routine breast cancer care-who participates and does it help? Psychooncology 2008; 17: 716-720
67. Cameron LD, Booth RJ, Schlatter M, et al. Changes in emotion regulation and psychological adjustment following use of a group psychosocial support program for women recently diagnosed with breast cancer. Psychooncology 2007; 16:171-180
68. Vos PJ, Visser AP, Garssen B, et al. Effectiveness of group psychotherapy compared to social support groups in patients with primary, non-metastatic breast cancer. J Psychosoc Oncol 2007; 25: 37-60.
69. Chan CL, Ho RT, Lee PW, et al. A randomized controlled trial of psychosocial interventions using the psychophysiological framework for Chinese breast cancer patients. J Psychosoc Oncol 2006; 24:3-26.
70. Antoni MH, Wimberly SR, Lechner SC, et al. Reduction of cancer-specific thought intrusions and anxiety symptoms with a stress management intervention among women undergoing treatment for breast cancer. Am J Psychiatry 2006; 163:1791-1797
71. Antoni MH, Lechner SC, Kazi A, et al. How stress management improves quality of life after treatment for breast cancer. J Consult Clin Psychol 2006; 74:1143-1152
72. Tatrow K, Montgomery GH. Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis. J Behav Med 2006; 29:17-27.
73. Savard J, Simard S, Ivers H, et al. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncol 2005; 23: 6083-6096
74. Savard J, Simard S, Ivers H, et al. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: immunologic effects. J Clin Oncol 2005; 23: 6097-6106
75. Matchim Y, Armer JM. Measuring the psychological impact of mindfulness meditation on health among patients with cancer: a literature review. Oncol Nurs Forum 2007; 34: 1059-1066
76. Smith JE, Richardson J, Hoffman C, et al. Mindfulness-based stress reduction as supportive therapy in cancer care: systematic review. J Adv Nurs 2005; 52:315-327
77. Carlson LE, Speca M, Patel KD, et al. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 2004; 29: 448-474
78. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med 2003; 65: 571-581
79. Schnur JB, Montgomery GH. Hypnosis and cognitive-behavioral therapy during breast cancer radiotherapy: a case report. Am J Clin Hypn 2008; 50: 209-215
80. Hudacek KD. A review of the effects of hypnosis on the immune system in breast cancer patients: a brief communication. Int J Clin Exp Hypn 2007; 55: 411-425
81. Nunes DF, Rodriguez AL, da Silva Hoffmann F, et al. Relaxation and guided imagery program in patients with breast cancer undergoing radiotherapy is not associated with neuroimmunomodulatory effects. J Psychosom Res 2007; 63: 647-655
82. Biegler KA, Chaoul MA, Cohen L. Cancer, cognitive impairment, and meditation. Acta Oncol 2009; 48:18-26.
83. Culos-Reed SN, Carlson LE, Daroux LM, et al. Pilot study of yoga for breast cancer survivors: physical and psychological benefits. Psychooncology 2006; 15:891-897
84. Carson JW, Carson KM, Porter LS, et al. Yoga for women with metastatic breast cancer: results from a pilot study. J Pain Symptom Manage 2007; 33: 331-341
85. Kissane DW, Grabsch B, Clarke DM, et al. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology 2007; 16: 277-286
86. Savard J, Simard S, Giguère I, et al. Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects. Palliat Support Care 2006; 4: 219-237
87. Gil KM, Mishel MH, Belyea M, et al. Benefits of the uncertainty management intervention for african american and white older breast cancer survivors: 20-month outcomes. Int J Behav Med 2006; 13: 286-294
88. Mishel MH, Germino BB, Gil KM, et al. Benefits from an uncertainty management intervention for african-american and caucasian older long-term breast cancer survivors. Psychooncology 2005; 14: 962-978
89. Cimprich B, Janz NK, Northouse L, et al. Taking charge: A selfmanagement program for women following breast cancer treatment. Psychooncology 2005; 14: 704-717